Immune-epithelial-stromal networks define the cellular ecosystem of the small intestine in celiac disease.
FitzPatrick MEB., Antanaviciute A., Dunstan M., Künnapuu K., Trzupek D., Provine NM., Dooley K., Zhang J-Y., Irwin SL., Garner LC., Pernes JI., Ferreira RC., Sasson SC., Aschenbrenner D., Agarwal D., Rodrigues A., Howarth L., Brain O., Ruane D., Soilleux E., Teichmann SA., Dendrou CA., Simmons A., Uhlig HH., Todd JA., Klenerman P.
The immune-epithelial-stromal interactions underpinning intestinal damage in celiac disease (CD) are incompletely understood. To address this, we performed single-cell transcriptomics (RNA sequencing; 86,442 immune, parenchymal and epithelial cells; 35 participants) and spatial transcriptomics (20 participants) on CD intestinal biopsy samples. Here we show that in CD, epithelial populations shifted toward a progenitor state, with interferon-driven transcriptional responses, and perturbation of secretory and enteroendocrine populations. Mucosal T cells showed numeric and functional changes in regulatory and follicular helper-like CD4+ T cells, intraepithelial lymphocytes, CD8+ and γδ T cell subsets, with skewed T cell antigen receptor repertoires. Mucosal changes remained detectable despite treatment, representing a persistent immune-epithelial 'scar'. Spatial transcriptomics defined transcriptional niches beyond those captured in conventional histological scores, including CD-specific lymphoid aggregates containing T cell-B cell interactions. Receptor-ligand spatial analyses integrated with disease susceptibility gene expression defined networks of altered chemokine and morphogen signaling, and provide potential therapeutic targets for CD prevention and treatment.